Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

38.52
Delayed Data
As of Apr 29
 -0.68 / -1.73%
Today’s Change
27.68
Today|||52-Week Range
40.96
-3.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues281.9M312.7M450.1M522.8M
 
 
 
 
 
Cost of Goods Sold34.9M43.2M86.0M89.0M
 
 
 
 
 
Depreciation And Amortization11.2M19.0M32.5M35.3M
 
 
 
 
 
 
Operating ExpensesGross Income235.8M250.6M331.7M398.5M
 
 
 
 
 
General Expenses199.2M204.4M270.0M302.1M
 
 
 
 
 
Research And Development123.2M119.9M150.8M150.4M
 
 
 
 
 
Total Operating Expenses245.3M266.5M388.4M426.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income36.6M46.2M61.8M96.4M
 
 
 
 
 
Extraordinary Credit3.0M0.00--9.4M
 
 
 
Extraordinary Charge-9.6M-3.4M-3.7M-9.8M
 
 
 
 
 
Interest Expense On Debt2.2M2.0M10.7M9.4M
 
 
 
 
 
Other Expenses2.0M426.0K2.9M-319.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income32.1M43.4M53.1M89.8M
 
 
 
 
 
Income Taxes-13.9M-13.1M-16.3M-26.9M
 
 
 
 
 
Minority Interest-5.4M-876.0K0.000.00
 
 
 
Net Income23.5M31.1M36.7M62.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.1M36.2M37.3M38.6M
 
 
 
 
 
Shares To Calculate EPS Diluted36.4M36.7M45.8M47.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.65$0.85$0.88$1.41
 
 
 
 
 
EPS Diluted$0.65$0.85$0.88$1.41